Atlas Venture is a Cambridge, Massachusetts biotech venture firm founded in 1993 that seeds and builds breakthrough biotechnology companies, typically leading first institutional rounds. It raised a fourteenth fund of $450 million and co-founded companies including Intellia Therapeutics, Translate Bio, Nimbus Therapeutics and Kymera Therapeutics.

Firm Profile

Notable Partners

Portfolio Companies (4)

Investment Focus

Bio VCEarly-stage

Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of recent date. Refreshed periodically.